McIlrath & Eck, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
McIlrath & Eck, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,220
-41.7%
2,000
-20.0%
0.00%
-50.0%
Q2 2023$8,950
+36.9%
2,500
-16.7%
0.00%0.0%
Q1 2023$6,540
-81.9%
3,0000.0%0.00%
-77.8%
Q4 2022$36,090
+89.9%
3,0000.0%0.01%
+80.0%
Q3 2022$19,000
+35.7%
3,0000.0%0.01%
+25.0%
Q2 2022$14,000
-46.2%
3,0000.0%0.00%
-50.0%
Q1 2022$26,000
-39.5%
3,0000.0%0.01%
-33.3%
Q4 2021$43,000
-34.8%
3,0000.0%0.01%
-40.0%
Q3 2021$66,000
+22.2%
3,000
-25.0%
0.02%
+25.0%
Q2 2021$54,0004,0000.02%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders